The U.S. Patent and Trademark Office’s policy of rejecting applications to register trademarks that identify nonhemp cannabis products, as well as certain hemp CBD products,[1] reflects an unduly doctrinaire approach that ultimately makes Americans less safe.
Fred Rocafort in Law360
